日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial

Avelumab 联合 Talazoparib 治疗 BRCA1/2 或 ATM 基因改变的晚期实体瘤患者：JAVELIN BRCA/ATM 研究结果，一项开放标签、多中心、2b 期、肿瘤类型无关试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2022.5218
Schram, Alison M; Colombo, Nicoletta; Arrowsmith, Edward; Narayan, Vivek; Yonemori, Kan; Scambia, Giovanni; Zelnak, Amelia; Bauer, Todd M; Jin, Ning; Ulahannan, Susanna V; Colleoni, Marco; Aftimos, Philippe; Donoghue, Mark T A; Rosen, Ezra; Rudneva, Vasilisa A; Telli, Melinda L; Domchek, Susan M; Galsky, Matthew D; Hoyle, Margaret; Chappey, Colombe; Stewart, Ross; Blake-Haskins, John A; Yap, Timothy A
ATM
肿瘤
肿瘤免疫
BRCA1
发表日期：2023
文献求助 收藏

Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial

图卡替尼联合曲妥珠单抗和卡培他滨治疗既往接受过治疗的ERBB2（HER2）阳性转移性乳腺癌脑转移患者的疗效：HER2CLIMB随机临床试验的最新探索性分析

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2022.5610
Lin, Nancy U; Murthy, Rashmi K; Abramson, Vandana; Anders, Carey; Bachelot, Thomas; Bedard, Philippe L; Borges, Virginia; Cameron, David; Carey, Lisa A; Chien, A Jo; Curigliano, Giuseppe; DiGiovanna, Michael P; Gelmon, Karen; Hortobagyi, Gabriel; Hurvitz, Sara A; Krop, Ian; Loi, Sherene; Loibl, Sibylle; Mueller, Volkmar; Oliveira, Mafalda; Paplomata, Elisavet; Pegram, Mark; Slamon, Dennis; Zelnak, Amelia; Ramos, Jorge; Feng, Wentao; Winer, Eric
肿瘤
HER2
肿瘤免疫
ERBB2
神经科学
乳腺癌
发表日期：2023
文献求助 收藏

Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer

利用Oncotype DX乳腺复发评分®检测来确定新辅助内分泌治疗在早期激素受体阳性乳腺癌中的作用

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-06890-7
Taylor, Caitlin; Meisel, Jane; Foreman, Aimee J; Russell, Christy; Bandyopadhyay, Dipankar; Deng, Xiaoyan; Floyd, Lisa; Zelnak, Amelia; Bear, Harry; O'Regan, Ruth
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

转移性三阴性乳腺癌患者 sacituzumab govitecan 与化疗对比的 III 期 ASCENT 研究中生物标志物分析

期刊:Annals of Oncology
影响因子:56.7
doi:10.1016/j.annonc.2021.06.002
A Bardia, S M Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, A Zelnak, P Aftimos, F Dalenc, S Sardesai, E Hamilton, P Sharma, S Recalde, E C Gil, T Traina, J O'Shaughnessy, J Cortes, M Tsai, L Vahdat, V Diéras, L A Carey, H S Rugo, D M Goldenberg, Q Hong, M Olivo, L M Itri, S A Hurvitz
肿瘤
乳腺癌
发表日期：2021
文献求助 收藏

Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR(+)/HER2(-) Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)

依西美坦、瑞博西尼和依维莫司治疗 CDK4/6 抑制剂治疗后进展的 HR(+)/HER2(-) 晚期乳腺癌女性患者的 I/II 期试验 (TRINITI-1)

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-20-2114
Bardia, Aditya; Hurvitz, Sara A; DeMichele, Angela; Clark, Amy S; Zelnak, Amelia; Yardley, Denise A; Karuturi, Meghan; Sanft, Tara; Blau, Sibel; Hart, Lowell; Ma, Cynthia; Rugo, Hope S; Purkayastha, Das; Moulder, Stacy
CDK4
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial

在 HER2CLIMB 试验中，图卡替尼联合曲妥珠单抗和卡培他滨治疗既往接受过治疗的 HER2 阳性乳腺癌脑转移患者的颅内疗效和生存率

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.00775
Lin, Nancy U; Borges, Virginia; Anders, Carey; Murthy, Rashmi K; Paplomata, Elisavet; Hamilton, Erika; Hurvitz, Sara; Loi, Sherene; Okines, Alicia; Abramson, Vandana; Bedard, Philippe L; Oliveira, Mafalda; Mueller, Volkmar; Zelnak, Amelia; DiGiovanna, Michael P; Bachelot, Thomas; Chien, A Jo; O'Regan, Ruth; Wardley, Andrew; Conlin, Alison; Cameron, David; Carey, Lisa; Curigliano, Giuseppe; Gelmon, Karen; Loibl, Sibylle; Mayor, JoAl; McGoldrick, Suzanne; An, Xuebei; Winer, Eric P
肿瘤
HER2
肿瘤免疫
神经科学
乳腺癌
发表日期：2020
文献求助 收藏

The 21-gene recurrence score and locoregional recurrence in breast cancer patients

21基因复发评分与乳腺癌患者的局部区域复发

期刊:Annals of Surgical Oncology
影响因子:3.5
doi:10.1245/s10434-014-4252-y
Jegadeesh, Naresh K; Kim, Sunjin; Prabhu, Roshan S; Oprea, Gabriela M; Yu, David S; Godette, Karen G; Zelnak, Amelia B; Mister, Donna; Switchenko, Jeffrey M; Torres, Mylin A
肿瘤
肿瘤免疫
乳腺癌
发表日期：2015
文献求助 收藏

Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy

新辅助化疗和乳房切除术后未接受放射治疗的雌激素受体阳性乳腺癌伴淋巴结残留病灶患者的局部区域复发风险

期刊:International Journal of Breast Cancer
影响因子:3
doi:10.1155/2015/147476
Kandula, Shravan; Switchenko, Jeffrey M; Harari, Saul; Fasola, Carolina; Mister, Donna; Yu, David S; Zelnak, Amelia B; Torres, Mylin A
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2015
文献求助 收藏

Current approaches to the treatment of metastatic brain tumours

目前治疗转移性脑肿瘤的方法

期刊:Nature Reviews Clinical Oncology
影响因子:82.2
doi:10.1038/nrclinonc.2014.25
Owonikoko, Taofeek K; Arbiser, Jack; Zelnak, Amelia; Shu, Hui-Kuo G; Shim, Hyunsuk; Robin, Adam M; Kalkanis, Steven N; Whitsett, Timothy G; Salhia, Bodour; Tran, Nhan L; Ryken, Timothy; Moore, Michael K; Egan, Kathleen M; Olson, Jeffrey J
肿瘤
肿瘤免疫
神经科学
发表日期：2014
文献求助 收藏